Search Results

MustGrow and Janssen PMP, a division of Janssen Pharmaceutica NV, Announce Significant Project Expansion

MustGrow Biologics Corp. (TSXV: MGRO) (OTCQB: MGROF) (FSE: 0C0) (the “Company” or “MustGrow”), and Janssen PMP, a division of Janssen Pharmaceutica NV, one of the Janssen Pharmaceutical Companies of Johnson & Johnson (NYSE: JNJ) (“Janssen PMP”) are pleased to announce a significant expansion to their existing Exclusive Evaluation and Option Agreement

September 6, 2023

·

9 min read

Business

Alkermes Announces Second Interim Award in Janssen Pharmaceutica Arbitration

Alkermes plc (Nasdaq: ALKS) today announced that on April 19, 2023 it received a second interim award (the “Second Interim Award”) from the arbitral tribunal (the “Tribunal”) in its arbitration proceedings in respect of two license agreements with Janssen Pharmaceutica N.V.

April 25, 2023

·

4 min read

MustGrow and Janssen PMP, a Division of Janssen Pharmaceutica NV, Extend Exclusive Global Partnership

MustGrow Biologics Corp. (TSXV: MGRO) (OTCQB: MGROF) (FSE: 0C0) (the “Company”, “MustGrow”), and JANSSEN PMP, a division of Janssen Pharmaceutica NV, one of the Janssen Pharmaceutical Companies of Johnson & Johnson

May 23, 2023

·

7 min read

Press Releases

Vivoryon Therapeutics N.V. Shares Highlights from Virtual R&D Update with KOL Speakers

February 19, 2025

·

8 min read

Press Releases

QIAGEN N.V. to Release Results for Q4 2024 and Hold Webcast

January 15, 2025

·

1 min read

Press Releases

Mainz Biomed N.V. Regains Compliance with Nasdaq Capital Market Listing Requirements

January 27, 2025

·

3 min read

Press Releases

Vivoryon Therapeutics N.V. to Host Virtual R&D Update with KOL Speakers on February 18, 2025

February 11, 2025

·

4 min read

Business

Predicine Announces Collaboration with Janssen to Develop PredicineCARE™ as a Companion Diagnostic Assay in Localized Bladder Cancer

Predicine, Inc., a leading molecular insights company, announced a collaboration with Janssen Pharmaceutica NV, a Johnson & Johnson company.

January 8, 2024

·

2 min read

Press Releases

Vivoryon Therapeutics N.V. Provides R&D-Update Further Strengthening Development Pipeline in Kidney Disease

January 14, 2025

·

10 min read

Policy

Alkermes Commences Arbitration Related to License Agreements with Janssen Pharmaceutica

Alkermes plc (Nasdaq: ALKS) today announced that it commenced binding arbitration proceedings in respect of two license agreements with Janssen Pharmaceutica N.V. (“Janssen”), a subsidiary of Johnson & Johnson.

April 19, 2022

·

4 min read